Duolingo shows strong sales and FCF, but DAU and MAU growth are rapidly decelerating, signaling limited reinvestment opportunities. See why DUOL stock is a hold.
ANI Pharmaceuticals delivered strong Q4 and FY25 results, with revenue up 30% and record Cortrophin Gel growth. Read why ANIP stock is rated a hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results